3°Corso Dermatologia, Immunologia e Allergologia ... · → histamine vs. antihistamine Simons F....
Transcript of 3°Corso Dermatologia, Immunologia e Allergologia ... · → histamine vs. antihistamine Simons F....
AGORA’ 2016
3° Corso Dermatologia, Immunologia e Allergologia Dermatologica
Antistaminici: pro e controMaria Filomena Caiaffa
Professore di Allergologia ed Immunologia Clinica Presidente di Corso di Laurea di Medicina e Chirurgia
Università di Foggia
AntihistaminesAntihistamines → available since the 1950sH1 receptor antagonistsHistamine → H1 receptors on endothelial cells (the wheal) and on sensory nerves (pruritus) → active conformationAntihistamines → same H1 receptors → inactive conformationEfficacy proportional to receptor occupancy → histamine vs. antihistamine
Simons F. N Eng J Med 351:2203-2217, 2004.
Antihistamines• Chemical Class First generation agents Second generation agents
Alkylamines → Chlorpheniramine(Trimeton)BrompheniramineTriprolidine Acrivastine
Piperazines → OxatomideHydroxyzine Cetirizine(Atarax) Levocetirizine
Ethanolamines → Diphenydramine
Phenotiazines → Promethazine(Farganesse)
Piperidines → Azatadine Astemizole*, Terfenadine*,Ketotifene Bilastine, Ebastine,Ciproeptadine Rupatadine, Loratadine
Fexofenadine
Tryciclic Antidepressant → Doxepin Azelastine
First generation H1-antihistamines
Pronounced anthicolinergic effects and sedative actions on the central nervous system (CNS)
Interactions with alcohol and CNS drugs (analgesics, hypnotics, sedative)Impact on concentration, learning and performance (risk increased in the elderly and children)Side effects most pronounced in Promethazine, Ketotifen, Diphenydramine, Chlorpheniramine (hospital use → premedication in allergic patients)
Penetrate blood-brain barrier and bind to H-1 receptors in the CNS
Zuberbier et al. The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria. : the 2013 definition and update Allergy 69:868-887, 2014.
Second generation H1-antihistamines
Minimum or none sedating effects
Free of anticholinergic effects
Two of earlier second generation drugs astemizole and terfenadine→ cardiotoxic effects → if concomitant administration of erythromycin or ketoconazole
First line → syntomatic treatment for urticaria
Second line → increase dosage up to fourfold (desloratadine, levocetirizine, bilastine, fexofenadine, rupatadine)
Once daily administrationRapid onset and 24 hour duration of action
Zuberbier et al. The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria. : the 2013 definition and update Allergy 69:868-887, 2014.AIFA, 2015
In pregnancy → cetirizine, loratadine
Management of chronic ordinary urticaria: general principles
Continuous treatment with second generation H1-antihistamines Safety data are available for use of several years continuouslyLow sedation antihistamines should be taken regularly – not only when symptoms occurSedative antihistamine e.g. hydroxyzine 25mg before sleep if nocturnal pruritus is a problem (possible impairment of cognitive function the following morning)
Finn AJ, Kaplan A, Fretwell R. J Allergy Clin Immunol 103:1071-1078, 1999.Nelson H, Reynolds R, Mason J. Annals Allergy Asthma Immunol 84:517-522, 2000.LaRosa M, Leonardi S, Marchese G, et. al. Annals Allergy Asthma Immunol 87:48-53, 2001.Zuberbier et al. The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria. : the 2013 definition and update Allergy 69:868-887, 2014.
Management of allergic
rhinitis: general principles
• First line treatment for mild allergic rhinitis
• Effective for Rhinorrhea, Nasal pruritus, Sneezing
• Less effective for Nasal blockage
• Possible additional anti-allergic and anti-inflammatory effect (in-vitro effect > in-vivo effect)
• Minimal or no sedative effects
• Once daily administration
• Rapid onset and 24 hour duration of action
Newer generation oral antihistamines
PlaceboN =201
Fexofenadine 120 mgN =211
Fexofenadine 180 mgN =202
Cetirizine 10 mgN =207
** **
Change frombaseline in
total symptomscore
0
-0.5
-1.0
-1.5
-2.0
-2.5
-3.0
Newer antihistamines are equally effectivein the treatment of allergic rhinitis
Howarth P et al. J Allergy Clin Immunol 1999;104:927
*: <0.05 compared to placeboBaseline symptomsStudy duration
**
Bachert C et al. J Allergy Clin Immunol 2004:114:838
Efficacy of an antihistamine over 6 months inpersistent allergic rhinitis
Sneezing Rhinorrhea Pruritus Nose Pruritus Eyes Congestion
*
*
*
*
*
*
*
*
*
*
*
*
*
1.0
0.8
0.6
0.4
0.2
01 wk
4 wk6 mo 1 wk
4 wk6 mo 1 wk
4 wk6 mo 1 wk
4 wk6 mo 1 wk
4 wk6 mo
meanIndividualsymptom
scoreimprovement
* P<0.05
Levocetirizine, 5 mg, N = 276Placebo, N = 271
Baseline total symptom score: 8.95
Nasal antihistamines
• Azelastine
• Levocabastine
• Olopatadine
Modified from van Cauwenberge P Allergy 2000;55:116-134
Agents and actionsOral
antihistamines
Nasal antihistamines
Cys-LT1 receptor
antagonists
Nasal steroids
Nasal decongestants
Oral decongestants
Nasal ipratrop
ium
Nasal cromon
es
Rhinorrhea + + ++ ++ +++ 0 0 +++ +
Congestion + + + +++ ++++ ++ 0 +
Sneezing ++ ++ ++ +++ 0 0 0 +
Pruritus ++ ++ + +++ 0 0 0 +
Ocular symptoms ++ 0 ++ ++ 0 0 0 0
Onset of action 1 hr 15 min 48 hr 12 hr 5-15
min 1 hr 15-30 min -
Duration 12-24 hr 6-12 hr 24 hr 12-48 hr 3-6 hr 12-24 hr 4-12 hr 2-6 hr
Terapia intranasaleAssociazione antistaminico/corticosteroide
Treatment days
Riduzione di almeno il 50% del TNSSRe
spon
ders (%
)
Giorni di trattamento
Inizio
FP+AZE
Carr W et al. A novel intranasal therapy of Azelastine with Fluticasone for the treatment of Allergic Rhinitis. J Allergy Clin Immunol 2012;129(5):1282-89
TNSS Total Nasal Symptom Score
Management della rinite allergica
La terapia farmacologica antistaminica è sintomatica
L’Immunoterapia allergenicarappresenta l’unico trattamento
immunomodulatorio antigene-specifico in grado di modificare la storia naturale
della malattia
University of BariMarcello Albanesi Attilio Di GirolamoIrene Fiorino Flavia Frisenda Valentina LaudadioAndrea NicoCarlo PasculliLuigi Macchia
University of FoggiaLuciana d’EliaElena MinennaMaria Luisa TaurinoMaria F. Caiaffa
Polo Biomedico“Emanuele Altomare”